PRIOR PRINTER'S NO. 3376
PRINTER'S NO. 3505
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
893
Session of
2015
INTRODUCED BY READSHAW, BARBIN, PAYNE, CALTAGIRONE, HARPER,
FREEMAN, D. COSTA, VEREB, COHEN, PASHINSKI, TAYLOR, ROTHMAN,
KIRKLAND, HEFFLEY, WARD, JAMES, SCHLOSSBERG, McNEILL,
V. BROWN, DRISCOLL, NEILSON, O'BRIEN, DONATUCCI, GIBBONS,
SAYLOR, STAATS, MILNE, BURNS, GABLER, GINGRICH AND MAJOR,
MAY 18, 2016
AS REPORTED FROM COMMITTEE ON HUMAN SERVICES, HOUSE OF
REPRESENTATIVES, AS AMENDED, JUNE 13, 2016
A RESOLUTION
Directing the Joint State Government Commission to conduct a
study and publish a report on the benefits, costs and
drawbacks of alternative opioid dependence treatment programs
that utilize Federal Food and Drug Administration-approved
medications.
WHEREAS, Pennsylvania families are at the front lines of the
opiate epidemic in this Commonwealth, with approximately seven
individuals dying each day from opioid-induced overdoses; and
WHEREAS, The opioid problem in this Commonwealth has grown to
epidemic proportions and is a major health hazard for all
Pennsylvanians; and
WHEREAS, We, as a community, must stop simply talking about
the issue and begin looking for viable options to combat this
disease and provide individuals with all avenues for recovery;
therefore be it
RESOLVED, That the House of Representatives direct the Joint
State Government Commission to conduct a study and publish a
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17